Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7127 per EA under NDC 72205004211. Its NADAC has been published 290 times since Dec 9, 2020.
Strength
30 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205004211
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA212544On Market Since
8/25/2020
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 290 times since Dec 9, 2020, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $3.3508 (Apr 14, 2021) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.1960 |
| Average price | $1.4795 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 290 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Novadoz Pharmaceuticals LLC, is $0.7127 per EA (NDC 72205004211), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 78.7%. It has been tracked across 290 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Dec 9, 2020, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $3.3508 (Apr 14, 2021), with a median of $1.1960 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 72205004211) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification